| Ms Angela Louise Bowling, | |
|
3449 E Rezanof Dr, Kodiak, AK 99615-6952 | |
| (907) 486-9800 | |
| (907) 486-9898 |
| Full Name | Ms Angela Louise Bowling |
|---|---|
| Gender | Female |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 3449 E Rezanof Dr, Kodiak, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366741472 | NPI | - | NPPES |
| 1679514236 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Angela Louise Bowling, 3449 E Rezanof Dr, Kodiak, AK 99615-6952 Ph: (907) 486-9800 | Ms Angela Louise Bowling, 3449 E Rezanof Dr, Kodiak, AK 99615-6952 Ph: (907) 486-9800 |
News Archive
The first study of its kind in the world — involving 336 children aged between six months and 16 years old — has shown that installing a water softener for three months brings no additional relief for eczema sufferers.
Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that a recent series of in vitro studies conducted by Southern Research in Birmingham, Alabama, have demonstrated that its novel class of antimicrobials, named bisphosphocins, have proven effective at killing multidrug-resistant (MDR) strains of Mycobacterium tuberculosis, the bacteria responsible for the chronic lung infection tuberculosis.
In late 2013 the Caribbean had its first case of the mosquito-borne chikungunya virus. Today there have been almost 1.2 million cases in 44 countries or territories, including 177 cases in 31 U.S. States. Vanderbilt University Medical Center's James Crowe, M.D., Ann Scott Carell Professor and director of the Vanderbilt Vaccine Center, and his team are reporting the first large panel of antibody treatments against this disease in the current issue of Cell Host and Microbe.
Aeterna Zentaris Inc. today announced that it has reached an agreement with the U.S. Food and Drug Administration ("FDA") on a Special Protocol Assessment ("SPA") for an upcoming Phase 3 registration trial in endometrial cancer with its doxorubicin peptide conjugate, AEZS-108. The SPA agreement states that the proposed trial protocol design, clinical endpoints and planned analyses are acceptable to the FDA to support a regulatory submission.
› Verified 4 days ago
Michael Handricks, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3449 E Rezanof Dr, Kodiak, AK 99615 Phone: 907-486-9824 Fax: 907-486-3498 | |
Jordan Beard, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3449 E Rezanof Dr, Kodiak, AK 99615 Phone: 907-942-0672 | |
Mr. Ken E Mccarty, LMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 1423 Simeonof St, Kodiak, AK 99615 Phone: 530-515-1089 Fax: 530-241-9221 | |
Stephanie M Mccarter, Counselor Medicare: Not Enrolled in Medicare Practice Location: 717 E Rezanof Dr, Kodiak, AK 99615 Phone: 907-481-2434 | |
Mr. Phillip Anthony Jordinelli, CDCS, NCACI, SAP Counselor Medicare: Not Enrolled in Medicare Practice Location: 3449 E Rezanof Dr, Kodiak, AK 99615 Phone: 907-486-9823 Fax: 907-486-9898 | |
Hope Lee Livingston Rustemeyer, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3449 E Rezanof Dr, Kodiak, AK 99615 Phone: 907-486-7383 | |
Mr. Stephen Jay Foreman, LPC, NCC, NCSC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1944 E Rezanof Dr, Kodiak, AK 99615 Phone: 907-654-9653 |